Sertoli Treated Cord Blood for Spinal Cord Injury

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43NS050065-01
Agency Tracking Number: NS050065
Amount: $150,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
SANERON CCEL THERAPEUTICS, INC.
3650 Spectrum Blvd., UTC II, Suite 170, TAMPA, FL, 33612
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 CYNDY Davis
 (813) 866-6372
 CDH@SANERON-CCEL.COM
Business Contact
 NICOLE KUZMIN-NICHOLS
Phone: (813) 866-6371
Email: NKN@SANERON-CCEL.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Stem cells from human umbilical cord blood (hUCB) represent a promising cellular therapeutic strategy for the treatment of cord injury (SCI). These cells are capable of differentiating into neurons and glia in vivo

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government